Diagnosis of the Fatty Liver Disease

Reading time: 1 min
Liver biopsy to measure scarring or fibrosis of the liver

Liver biopsy: this is the diagnostic test par excellence. This shows the presence of fat (steatosis), the inflammation associated with it and fibrosis (scar tissue). Since it is an invasive test, different non-invasive diagnostic tools have appeared in recent years to detect the presence of fat and fibrosis.

HER2 membrane receptor cell

Serological biomarkers: these are compounds present in the blood. They are calculated from analytical parameters and data from the patient's medical history.

Ultrasound on a monitor

Abdominal ultrasound: This shows if the patient has fat in the liver or cirrhosis, but cannot detect intermediate stages of fibrosis.

Magnetic Resonance Imaging or MRI machine

CT and MRI: Can detect fat (steatosis) and cirrhosis but are not used in daily clinical practice due to their cost, radiation and low availability.

Ultrasound on a monitor

Transition elastography: This technique is capable of detecting and quantifying fibrosis and steatosis quickly and at low cost. It is a non-invasive technique, using ultrasound. It is used for diagnosis and evaluation of the fibrosis stage in patients and for monitoring. 

Substantiated information by:

Isabel Graupera Garcia-Milà
Marta Cervera Carbonell
Pere Ginès Gibert

Published: 19 August 2022
Updated: 26 August 2022

The donations that can be done through this webpage are exclusively for the benefit of Hospital Clínic of Barcelona through Fundació Clínic per a la Recerca Biomèdica and not for BBVA Foundation, entity that collaborates with the project of PortalClínic.


Receive the latest updates related to this content.

Thank you for subscribing!

If this is the first time you subscribe you will receive a confirmation email, check your inbox

An error occurred and we were unable to send your data, please try again later.